Pretomanid Recruiting Phase 3 Trials for Non-responsive Multidrug-Resistant Pulmonary TB / Pre-Extensively Drug-Resistant Pulmonary TB / Treatment Intolerant Multidrug-Resistant Pulmonary TB Treatment

Indications	Status	Purpose	Phase
DBCOND0142670 (Non-responsive Multidrug-Resistant Pulmonary TB) DBCOND0142668 (Pre-Extensively Drug-Resistant Pulmonary TB) DBCOND0142669 (Treatment Intolerant Multidrug-Resistant Pulmonary TB)	Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT05040126	Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India	Bedaquiline (DB08903) Linezolid (DB00601) Pretomanid (DB05154)